• Expert review of vaccines · Jan 2019

    Review

    The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.

    • Reinaldo Acevedo, Xilian Bai, Ray Borrow, Dominique A Caugant, Josefina Carlos, Mehmet Ceyhan, Hannah Christensen, Yanet Climent, Philippe De Wals, Ener Cagri Dinleyici, Gabriela Echaniz-Aviles, Ahmed Hakawi, Hajime Kamiya, Andromachi Karachaliou, Jay Lucidarme, Susan Meiring, Konstantin Mironov, Sáfadi Marco A P MAP 0000-0002-4401-9446 o Department of Pediatrics , FCM Santa Casa de São Paulo School of Medical Sciences , São Paulo , Brazil., Zhujun Shao, Vinny Smith, Robert Steffen, Bianca Stenmark, Muhamed-Kheir Taha, Caroline Trotter, Julio A Vázquez, and Bingqing Zhu.
    • a Biologic Evaluation Department , Finlay Institute of Vaccines , Havana , Cuba.
    • Expert Rev Vaccines. 2019 Jan 1; 18 (1): 15-30.

    IntroductionThe 2018 Global Meningococcal Initiative (GMI) meeting focused on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and protection strategies worldwide, with emphasis on emerging antibiotic resistance and protection of high-risk populations. The GMI is comprised of a multidisciplinary group of scientists and clinicians representing institutions from several continents.Areas CoveredGiven that the incidence and prevalence of IMD continually varies both geographically and temporally, and surveillance systems differ worldwide, the true burden of IMD remains unknown. Genomic alterations may increase the epidemic potential of meningococcal strains. Vaccination and (to a lesser extent) antimicrobial prophylaxis are the mainstays of IMD prevention. Experiences from across the globe advocate the use of conjugate vaccines, with promising evidence growing for protein vaccines. Multivalent vaccines can broaden protection against IMD. Application of protection strategies to high-risk groups, including individuals with asplenia, complement deficiencies and human immunodeficiency virus, laboratory workers, persons receiving eculizumab, and men who have sex with men, as well as attendees at mass gatherings, may prevent outbreaks. There was, however, evidence that reduced susceptibility to antibiotics was increasing worldwide.Expert CommentaryThe current GMI global recommendations were reinforced, with several other global initiatives underway to support IMD protection and prevention.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…